Trademark search for:

FESTINAVIR

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2008-02-05 — Application filed
2008-03-06 — Sn assigned for sect 66a appl from ib
2008-03-07 — Limitation of goods/services from ib entered
2008-03-10 — Application filed
2008-05-15 — Assigned to examiner
2008-05-28 — Approved for pub - principal register
2008-05-28 — Assigned to lie
2008-05-30 — Law office publication review completed
2008-06-18 — Notice of publication
2008-07-08 — Published for opposition
2008-09-23 — Registered-principal register
2015-04-24 — Cancelled section 71
2015-12-24 — Total invalidation of reg ext protection created
2016-03-03 — Total invalidation of reg ext protection sent to ib
2016-03-03 — Invalidation processed
2017-03-10 — Total invalidation processed by the ib
2018-02-05 — Final status recorded
2018-08-31 — Death of international registration
2018-08-31 — Notification of effect of cancellation of intl reg mailed
2018-11-30 — Undeliverable mail - no action taken

Owner Information

Oncolys BioPharma Inc.
JP

Correspondent

HASEGAWA Yoshiki, c/o SOEI Patent and Law Firm
Ginza First Bldg.,
10-6, Ginza 1-chome,
Tokyo 104-0061,

Filing Details

Filing Date:
2008-02-05

Status Date:
2018-02-05

Category:
Pharmaceuticals

Filing Year:
2008

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.